Glia Nova Nyilvanosan Mukodo Reszvenytarsasag

As of December 31, 2025, Glia Nova Nyilvanosan Mukodo Reszvenytarsasag carries a market capitalization of 833.86M, placing it among publicly traded companies globally. Its enterprise value stands at 876.41M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, Glia Nova Nyilvanosan Mukodo Reszvenytarsasag has 10.29M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Glia Nova Nyilvanosan Mukodo Reszvenytarsasag maintains a current ratio of 1.60, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities.

As of the close on October 21, 2026, Glia Nova Nyilvanosan Mukodo Reszvenytarsasag's stock has declined approximately 15.00% over the past 52 weeks.

As of December 31, 2025, Glia Nova Nyilvanosan Mukodo Reszvenytarsasag holds 56,000.00 in cash and equivalents against 42.61M in total debt, resulting in a net debt position of 42.55M. Total book value stands at 2.40B, with working capital of 12.49M providing operational flexibility.